{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T04:17:27Z","timestamp":1773375447570,"version":"3.50.1"},"reference-count":21,"publisher":"Instituto Nacional de Salud (Colombia)","issue":"Sp. 3","license":[{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003033","name":"Ministerio de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003033","name":"Ministerio de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["revistabiomedica.org"],"crossmark-restriction":false},"short-container-title":["Biomed."],"abstract":"<jats:p>Introducci\u00f3n. La linfocitosis monoclonal de c\u00e9lulas B, generalmente, precede la leucemia linfoc\u00edtica cr\u00f3nica y afecta alrededor del 12 % de la poblaci\u00f3n adulta sana. Esta frecuencia se incrementa en familiares de pacientes con s\u00edndromes linfoproliferativos cr\u00f3nicos de c\u00e9lulas B.Objetivo. Determinar la frecuencia de linfocitosis monoclonal B en familiares de pacientes con s\u00edndromes linfoproliferativos cr\u00f3nicos B, sus caracter\u00edsticas inmunofenot\u00edpicas y citogen\u00e9ticas, posible relaci\u00f3n con agentes infecciosos, y seguimiento a corto plazo de poblaci\u00f3n colombiana.Materiales y m\u00e9todos. Se estudiaron 50 adultos sanos con antecedentes familiares de s\u00edndromes linfoproliferativos cr\u00f3nicos de c\u00e9lula B, empleando citometr\u00eda de flujo multiparam\u00e9trica, pruebas citogen\u00e9ticas y serol\u00f3gicas, encuesta de h\u00e1bitos de vida y seguimiento a dos a\u00f1os.Resultados. La frecuencia encontrada de linfocitosis monoclonal B fue del 8 %, con predominio del sexo femenino y edad avanzada, increment\u00e1ndose al 12,5 % en individuos con antecedentes familiares de leucemia linfoc\u00edtica cr\u00f3nica. Tres de cuatro individuos presentaron inmunofenotipo de tipo leucemia linfoc\u00edtica cr\u00f3nica, todas con bajo recuento. A su vez, en estos individuos se observa de manera significativa un mayor n\u00famero de c\u00e9lulas\/\u03bcl en subpoblaciones linfocitarias T, junto con mayor predisposici\u00f3n a la enfermedad. Las poblaciones clonales descritas aumentan a lo largo del tiempo de manera no significativa.Conclusiones. La frecuencia y comportamiento de la linfocitosis monoclonal de c\u00e9lula B en pacientes con antecedentes familiares de s\u00edndromes linfoproliferativos cr\u00f3nicos B es similar a lo encontrado en estudios relacionados, lo que sugiere que no existe afectaci\u00f3n de genes de mayor relevancia que puedan desencadenar una proliferaci\u00f3n clonal descontrolada, pero que generan desregulaci\u00f3n inmunol\u00f3gica que podr\u00eda indicar un mayor riesgo de infecci\u00f3n grave en estos individuos.<\/jats:p>","DOI":"10.7705\/biomedica.7099","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T09:35:40Z","timestamp":1704792940000},"page":"66-78","update-policy":"https:\/\/doi.org\/10.7705\/crossmark","source":"Crossref","is-referenced-by-count":1,"title":["Linfocitosis monoclonal de c\u00e9lulas B en familiares de pacientes colombianos con s\u00edndromes linfoproliferativos cr\u00f3nicos B","B-cell lymphocytosis in relatives of Colombian patients with chronic B-cell lymphoproliferative disorders"],"prefix":"10.7705","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6756-4260","authenticated-orcid":false,"given":"Mike","family":"Celis","sequence":"first","affiliation":[{"name":"Doctorado en Ciencias Biom\u00e9dicas, Facultad de Salud, Universidad del Valle, Cali, Colombia;\u00a0Instituto de Investigaci\u00f3n Masira, Facultad de Ciencias M\u00e9dicas y de la Salud, Universidad de Santander, Bucaramanga, Colombia"},{"name":"Doctorado en Ciencias Biom\u00e9dicas, Facultad de Salud, Universidad del Valle, Cali, Colombia;\u00a0Instituto de Investigaci\u00f3n Masira, Facultad de Ciencias M\u00e9dicas y de la Salud, Universidad de Santander, Bucaramanga, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3920-0232","authenticated-orcid":false,"given":"Yohanna","family":"Navarro","sequence":"additional","affiliation":[{"name":"Grupo de Investigaci\u00f3n Biom\u00e9dica Traslacional, Hospital Internacional de Colombia, Floridablanca, Colombia"},{"name":"Grupo de Investigaci\u00f3n Biom\u00e9dica Traslacional, Hospital Internacional de Colombia, Floridablanca, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3532-2002","authenticated-orcid":false,"given":"Norma","family":"Serrano","sequence":"additional","affiliation":[{"name":"Grupo de Investigaci\u00f3n Biom\u00e9dica Traslacional, Hospital Internacional de Colombia, Floridablanca, Colombia"},{"name":"Grupo de Investigaci\u00f3n Biom\u00e9dica Traslacional, Hospital Internacional de Colombia, Floridablanca, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3219-0753","authenticated-orcid":false,"given":"Daniel","family":"Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Masira, Facultad de Ciencias M\u00e9dicas y de la Salud, Universidad de Santander, Bucaramanga, Colombia"},{"name":"Instituto de Investigaci\u00f3n Masira, Facultad de Ciencias M\u00e9dicas y de la Salud, Universidad de Santander, Bucaramanga, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7462-4655","authenticated-orcid":false,"given":"Wendy","family":"Nieto","sequence":"additional","affiliation":[{"name":"Grupo de Investigaci\u00f3n Biom\u00e9dica Traslacional, Hospital Internacional de Colombia, Floridablanca, Colombia"},{"name":"Grupo de Investigaci\u00f3n Biom\u00e9dica Traslacional, Hospital Internacional de Colombia, Floridablanca, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4444","published-online":{"date-parts":[[2023,12,29]]},"reference":[{"key":"128950","unstructured":"Li YY, Hu DZ, Tian C. Research progress on diagnosis and treatment of B cell chronic lymphoproliferative disease--review. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018;26:1220-4. https:\/\/doi.org\/10.7534\/j.issn.1009-2137.2018.04.046"},{"key":"128951","doi-asserted-by":"crossref","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375-90. https:\/\/doi.org\/10.1182\/blood-2016-01-643569","DOI":"10.1182\/blood-2016-01-643569"},{"key":"128952","doi-asserted-by":"crossref","unstructured":"Strati P, Shanafelt TD. Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: Diagnosis, natural history, and risk stratification. Blood. 2015;126:454-62. https:\/\/doi.org\/10.1182\/blood-2015-02-585059","DOI":"10.1182\/blood-2015-02-585059"},{"key":"128953","doi-asserted-by":"crossref","unstructured":"Slager SL, Lanasa MC, Marti GE, Achenbach SJ, Camp NJ, Abbasi F, et al. Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families. Blood. 2021;137:2046-56. https:\/\/doi.org\/10.1182\/blood.2020006322","DOI":"10.1182\/blood.2020006322"},{"key":"128954","doi-asserted-by":"crossref","unstructured":"Shanafelt TD, Kay NE, Parikh SA, Achenbach SJ, Lesnick CE, Hanson CA, et al. Risk of serious infection among individuals with and without low count monoclonal B-cell lymphocytosis (MBL). Leukemia. 2021;35:239-44. https:\/\/doi.org\/10.1038\/s41375-020-0799-8","DOI":"10.1038\/s41375-020-0799-8"},{"key":"128955","doi-asserted-by":"crossref","unstructured":"Villegas-Gracia R, Franco-Alzate C, Rend\u00f3n-Henao J, Torres-Hern\u00e1ndez JD, Jaramillo-Arbel\u00e1ez PE. Frequency of monoclonal B-cell lymphocytosis in relatives of patients with chronic lymphocytic leukemia. Colomb Med. 2016;47:81-6.","DOI":"10.25100\/cm.v47i2.1879"},{"key":"128956","doi-asserted-by":"crossref","unstructured":"Goldin LR, Lanasa MC, Slager SL, Cerhan JR, Vachon CM, Strom SS, et al. Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families. Br J Haemato. 2010;151:152-8. https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08339.x","DOI":"10.1111\/j.1365-2141.2010.08339.x"},{"key":"128957","doi-asserted-by":"crossref","unstructured":"Nieto WG, Almeida J, Romero A, Teodosio C, L\u00f3pez A, Henriques AF, et al. Increased frequency (12%) of circulating chronic lymphocytic leukemia\u2013like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach. Blood. 2009;114:33-7. https:\/\/doi.org\/10.1182\/blood-2009-01-197368","DOI":"10.1182\/blood-2009-01-197368"},{"key":"128958","doi-asserted-by":"crossref","unstructured":"van Dongen JJM, Lhermitte L, B\u00f6ttcher S, Almeida J, van der Velden VHJ, Flores-Montero J, et al. EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia. 2012;26:1908-75. https:\/\/doi.org\/10.1038\/leu.2012.120","DOI":"10.1038\/leu.2012.120"},{"key":"128959","doi-asserted-by":"crossref","unstructured":"Kalina T, Flores-Montero J, van Der Velden VHJ, Martin-Ayuso M, B\u00f6ttcher S, Ritgen M, et al. EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols. Leukemia. 2012;26:1986-2010. https:\/\/doi.org\/10.1038\/leu.2012.122","DOI":"10.1038\/leu.2012.122"},{"key":"128960","doi-asserted-by":"crossref","unstructured":"De Faria-Moss M, Yamamoto M, Arrais-Rodrigues C, Criado I, Gomes CP, de Lourdes Chauffaille M, et al. High frequency of chronic lymphocytic leukemia-like low-count monoclonal B-cell lymphocytosis in Japanese descendants living in Brazil. Haematologica. 2020;105:e298. https:\/\/doi.org\/10.3324\/haematol.2019.230813","DOI":"10.3324\/haematol.2019.230813"},{"key":"128961","doi-asserted-by":"crossref","unstructured":"Criado I, Nieto WG, Oliva-Ariza G, Fuentes-Herrero B, Teodosio C, Lecrevisse Q, et al. Ageand sex-matched normal leukocyte subset ranges in the general population defined with the euroflow lymphocyte screening tube (LST) for monoclonal b-cell lymphocytosis (MBL) vs. non-MBL subjects. Cancers. 2022;15:58. https:\/\/doi.org\/10.3390\/cancers15010058","DOI":"10.3390\/cancers15010058"},{"key":"128962","doi-asserted-by":"crossref","unstructured":"Doody GM, Dempsey PW, Fearon DT. Activation of B lymphocytes: Integrating signals from CD19, CD22 and Fc gamma RIIb1. Curr Opin Immunol. 1996;8:378-82. https:\/\/doi.org\/10.1016\/S0952-7915(96)80128-2","DOI":"10.1016\/S0952-7915(96)80128-2"},{"key":"128963","doi-asserted-by":"crossref","unstructured":"Han X, Jorgensen JL, Brahmandam A, Schlette E, Huh YO, Shi Y, et al. Immunophenotypic study of basophils by multiparameter flow cytometry. Arch Pathol Lab Med. 2008;132:813-9. https:\/\/doi.org\/10.5858\/2008-132-813-ISOBBM","DOI":"10.5858\/2008-132-813-ISOBBM"},{"key":"128964","doi-asserted-by":"crossref","unstructured":"Kleinstern G, Weinberg JB, Parikh SA, Braggio E, Achenbach SJ, Robinson DP, et al. Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans. Leukemia. 2022;36:119-25. https:\/\/doi.org\/10.1038\/s41375-021-01344-9","DOI":"10.1038\/s41375-021-01344-9"},{"key":"128965","doi-asserted-by":"crossref","unstructured":"Kaastrup K, Gr\u00f8nb\u00e6k K. The impact of sedentary lifestyle, high-fat diet, tobacco smoke, and alcohol intake on the hematopoietic stem cell niches. HemaSphere. 2021;5:e615. https:\/\/doi.org\/10.1097\/HS9.0000000000000615","DOI":"10.1097\/HS9.0000000000000615"},{"key":"128966","doi-asserted-by":"crossref","unstructured":"Criado I, Rodr\u00edguez-Caballero A, Guti\u00e9rrez ML, Pedreira CE, Alcoceba M, Nieto W, et al. Low-count monoclonal B-cell lymphocytosis persists after seven years of follow up and is associated with a poorer outcome. Haematologica. 2018;103:1198. https:\/\/doi.org\/10.3324\/haematol.2017.183954","DOI":"10.3324\/haematol.2017.183954"},{"key":"128967","doi-asserted-by":"crossref","unstructured":"Popp HD, Flach J, Brendel S, Ruppenthal S, Kleiner H, Seifarth W, et al. Accumulation of DNA damage and alteration of the DNA damage response in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. Leuk Lymphoma. 2019;60:795-804. https:\/\/doi.org\/10.1080\/10428194.2018.1498494","DOI":"10.1080\/10428194.2018.1498494"},{"key":"128968","doi-asserted-by":"crossref","unstructured":"El Chaer F, Keng M, Ballen KK. MLL-rearranged acute lymphoblastic leukemia. Curr Hematol Malig Rep. 2020;15:83-9. https:\/\/doi.org\/10.1007\/s11899-020-00582-5","DOI":"10.1007\/s11899-020-00582-5"},{"key":"128969","doi-asserted-by":"crossref","unstructured":"Kostopoulos IV, Paterakis G, Pavlidis D, Kastritis E, Terpos E, Tsitsilonis OE, et al. Clonal evolution is a prognostic factor for the clinical progression of monoclonal B-cell lymphocytosis. Blood Cancer J. 2017;7:e597. https:\/\/doi.org\/10.1038\/bcj.2017.77","DOI":"10.1038\/bcj.2017.77"},{"key":"128970","doi-asserted-by":"crossref","unstructured":"K\u00fcppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer. 2005;5:251-62. https:\/\/doi.org\/10.1038\/nrc1589","DOI":"10.1038\/nrc1589"}],"container-title":["Biom\u00e9dica"],"original-title":[],"link":[{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/7099\/5325","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/7099\/5483","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/7099\/5325","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:10:41Z","timestamp":1773328241000},"score":1,"resource":{"primary":{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/view\/7099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,29]]},"references-count":21,"journal-issue":{"issue":"Sp. 3","published-online":{"date-parts":[[2023,12,29]]}},"URL":"https:\/\/doi.org\/10.7705\/biomedica.7099","relation":{},"ISSN":["2590-7379","0120-4157"],"issn-type":[{"value":"2590-7379","type":"electronic"},{"value":"0120-4157","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,29]]},"assertion":[{"value":"2023-12-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"Yes","order":0,"name":"peer_reviewed","label":"Peer Reviewed","group":{"name":"peer_review","label":"Peer Review"}},{"value":"Instituto Nacional de Salud","name":"publisher","label":"This article is maintained by"},{"value":"Biomedica","name":"journaltitle","label":"Journal Title"},{"value":"Art\u00edculos originales","name":"content_type","label":"Content Type"}]}}